Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linezolid”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Large-scale testing (Phase 3)Study completedNCT00035269
What this trial is testing

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Who this might be right for
Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
Pfizer 230
Testing effectiveness (Phase 2)Ended earlyNCT02732327
What this trial is testing

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Who this might be right for
NeoplasmsFebrile Neutropenia
Forest Laboratories 2
Not applicableStudy completedNCT01819935
What this trial is testing

Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

Who this might be right for
Pneumonia
Pfizer 5,271
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548426
What this trial is testing

Linezolid for Syphilis Pilot Study

Who this might be right for
Syphilis
University of Southern California 24
Post-approval studies (Phase 4)Looking for participantsNCT05571722
What this trial is testing

Linezolid or Vancomycin Surgical Site Infection Prophylaxis

Who this might be right for
Antibiotic ProphylaxisGeneral Surgery
Assistance Publique Hopitaux De Marseille 1,160
Post-approval studies (Phase 4)Study completedNCT00711854
What this trial is testing

Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

Who this might be right for
MRSA Infection
University Hospital, Geneva 150
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Testing effectiveness (Phase 2)Study completedNCT00949130
What this trial is testing

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Novexel Inc 180
Not applicableStudy completedNCT00177723
What this trial is testing

Towards Reducing Resistance and Hematological Toxicity of Linezolid

Who this might be right for
InfectionAdverse Effects
University of Pittsburgh 50
Not applicableStudy completedNCT02778828
What this trial is testing

Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis

Who this might be right for
Tuberculosis
Fondation Hôpital Saint-Joseph 31
Not applicableLooking for participantsNCT06590428
What this trial is testing

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Who this might be right for
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Albert Einstein College of Medicine 280
Large-scale testing (Phase 3)UnknownNCT04081077
What this trial is testing

PRACTECAL-PKPD Sub Study

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculosis
Medecins Sans Frontieres, Netherlands 240
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Large-scale testing (Phase 3)Study completedNCT00150332
What this trial is testing

Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

Who this might be right for
Infections, Nosocomial
Pfizer 24
Large-scale testing (Phase 3)Ended earlyNCT00359632
What this trial is testing

Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

Who this might be right for
Optic Nerve Diseases
Pfizer 34
Large-scale testing (Phase 3)Study completedNCT00035425
What this trial is testing

Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

Who this might be right for
Febrile Neutropenia
Pfizer 120
Not applicableStudy completedNCT01564758
What this trial is testing

Post Marketing Surveillance Study on Linezolid

Who this might be right for
Gram-Positive Bacterial Infections
Pfizer 99
Not applicableStudy completedNCT00666276
What this trial is testing

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Staphylococcal Infections
Pfizer 1,004
Next Page